chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Bacteria stool identified, Carbon dioxide decreased, Culture stool positive, Gastrointestinal haemorrhage, Haematocrit decreased
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Haemoglobin decreased, Heart rate increased, Intensive care, Intestinal resection, Intussusception
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Lethargy, Livedo reticularis, Red blood cell count decreased, Surgery, Swelling
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Gangrene, Life support, Peritonitis, Rectal haemorrhage, Small intestinal resection
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Intussusception, Small intestinal resection
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Bacteria stool identified, Carbon dioxide decreased, Gastrointestinal haemorrhage, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Heart rate increased, Intussusception, Lethargy, Life support, Livedo reticularis
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 0.2
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Rectal haemorrhage, Red blood cell count decreased, Small intestinal resection, Stool analysis abnormal, Swelling
Clinical narrative: Pt presented with GI bleed 3 days post vacinnation and became lethergic, mottled, with severe swelling. Pt was taken to the ED on 03/28. He was later found with acute intussusception and bowel was resected. Currently in PICU. 5/15/07 Received medical records from hospital which reveal patient experienced fussiness, bloody stools & massive GI bleed.  Initially seen at outlying ER where patient found to be in shock & transferred to higher level of care.  Admitted from 3/28-5/3/07.  Pulses & perfusion were extremely poor, he was tachycardic, poor urine output & he was cold & mottled.  Surgical consult done, central line placed & patient transfused.  Taken to OR on 4/3/07 where found ischemia & infarction of small bowel.  Resection of jejunum done; leaving only approx 30 cm jejunum.  Proximal jejunostomy created w/ileostomy & mucous fistula performed using approx 15 cm of terminal ileum.  Started on TPN & very slowly built up to 5 mL/TID at d/c oral feeding.  Treated w/multiple antibiotics while hospitalized & developed c. difficile.  Continued on TPN at d/c w/Home Health follow up due to high output jejunostomy.  FINAL DX: ischemia & infarction of small bowel; resection of small bowel w/creation of jejunostomy.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Headache
Clinical narrative: 1 1/2 hr after patient received Gardasil injection, pt developed "worse headache I ever had." lasting several hours.
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site swelling, Rash erythematous, Skin warm
Clinical narrative: Left thigh mildly swollen, erythematous rash, 2 x 6 cm. Left anterior aspect skin warm no tenderness no induration
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Anxiety, Fall, Loss of consciousness, Syncope
Clinical narrative: Approx 2-3 min after vaccine admin, pt experienced syncope episode with 2-3 sec loss of consciousness and fall to ground from own height. Pt had not eaten that day and had expressed anxiety re: immuniz. prior to event vs immediately after event BP-110/70; P-130/min, R-24/min, O2 sat 98%. Placed pt in recumbent position and gave her mild to drink. Fs OS-109 mg/dl. Fully recovered w/in 10 min BP-100/70; P-88/mm; R-16/mn O2 Sat 99%. Recovered at 11:55 in stable condition.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Dyspnoea, Hyperhidrosis, Pharyngeal oedema
Clinical narrative: Within 1 hr after pt left office per pt she experienced dizziness, sweating, SOB and throat swelling. Pt had to use albuterol inhaler.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema
Clinical narrative: Has redness on right outer upper arm x 7 days. Warm compress to site: Hydrocortisone cream TID x 1 week
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Swelling
Clinical narrative: 7 cm x 7 1/2 swollen red, notice just 4/3/07 apply ice in office to reduce swelling.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Mom into child with patients sisters. Mom asked PHN to look at his arms. Redness and swelling to both right and left arm where pt received. Mom reported his arms began to swell on 3-28-07. Pt is very playful without any fever. Doctor evaluated child and ordered elevate arm, cool compress. Benadryl TID x Advil with Motrin TID. RTC in am for recheck
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: 5cc of erythema/induration right u pper arm. Claritin, cool compresses.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Dysphonia, Erythema, Eyelid oedema, Rash, Swelling face
Clinical narrative: Red rash covering eye lids with edema facial swelling and hoarseness. No temp
Age: 68.0
Sex: M
Vaccine: FLU3, VARZOS
Symptoms: Cardiac stress test, Chills, Hyperhidrosis, Malaise, Paraesthesia
Clinical narrative: 9/28/06 shingles and Flu vaccine given separate arms. 10/30/06 wife called and stated 3-4 hrs after received vaccines pt didn't feel well, chills, teeth chattering, for 1/2 hrs, jumped out of chair, sweating, dripping water for 15 min. Bilateral shoulder and arm tingling 15 min wife thought from vaccines.
Age: 1.51
Sex: M
Vaccine: DTAP, FLU3, HIBV
Symptoms: Flushing, Rash
Clinical narrative: Rash noted on cheeks and arms (flushing in appearance) went away in 2 minutes. Gave Benadryl and Tylenol and observed pt for 30 mins still had normal exam No rash 4/5/07
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Rash
Clinical narrative: On 3/23/07, had "bump" with 2 smaller bumps" on labia. 3-24-07 another appeared, but  'first was almost gone" Referred to private physician.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Head banging, Muscle rigidity, Unresponsive to stimuli
Clinical narrative: Client presented health department for Menactra immunization and PPD, given 1 hour apart; following PPD, summoned to waiting room to assist; client reclined in chair not responding to name; breathing without difficulty; client's extremities became rigid; hyper-extended head and repeatedly thrust head against wall; episode lasted approximately 5-8 seconds followed by 10-15 seconds of semi-conscious responses; after episode, client able to sip small amounts of water and respond appropriately to questions; client escorted, via wheelchair, to exam room to rest while awaiting transportation to local ER for evaluation.
Age: 63.0
Sex: U
Vaccine: FLUX, PPV
Symptoms: Arthralgia, Chills, Feeling hot, Hypokinesia, Pain in extremity
Clinical narrative: Injection Pneumococcal vaccine approx 3:15 PM checked out of Hosp 6:30 PM arm very sore by this time. Continued to get sore by 9:00 PM whole of arm extreme pain, real hot to touch, to painful to move throwing up, chills. Shoulder still hurts in joint.
Age: 63.0
Sex: U
Vaccine: FLUX, PPV
Symptoms: Vomiting
Clinical narrative: Injection Pneumococcal vaccine approx 3:15 PM checked out of Hosp 6:30 PM arm very sore by this time. Continued to get sore by 9:00 PM whole of arm extreme pain, real hot to touch, to painful to move throwing up, chills. Shoulder still hurts in joint.
Age: 16.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site streaking
Clinical narrative: Co health center did not see client after adm of Tdap. School nurse contacted health center stating student had app 1/2: wide and 3 1/2" long faint but visible red area, streak from injection site. Health center called mom and ref. pt to her local doctor. Follow up calls to the home. Left message with pt for her mom to call health center. No response from parent. Pt stated they saw Dr. and no RX was made.
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Haematochezia
Clinical narrative: Blood in stool, starting day after vaccines lasting for about 1 1/2 weeks, no other problems
Sex: M
Vaccine: RV5
Symptoms: Haematochezia
Clinical narrative: Blood in stools for 1 1/2 weeks started day after Rotavirus vaccines
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Blood glucose normal, Dizziness, Fatigue, Gait disturbance, Hypotension
Clinical narrative: Dizziness, pt stated that she was feeling tired, faint, could not walk, almost passed, pale face, low blood pressure. But she was conscious the whole time. The whole episode happened about 10 minutes after receiving the vaccines. She was monitored in the office until she was feeling better. She walked out of the office at 1230 PM. Received the shots at 1140.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Pallor, Syncope
Clinical narrative: Dizziness, pt stated that she was feeling tired, faint, could not walk, almost passed, pale face, low blood pressure. But she was conscious the whole time. The whole episode happened about 10 minutes after receiving the vaccines. She was monitored in the office until she was feeling better. She walked out of the office at 1230 PM. Received the shots at 1140.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Fall
Clinical narrative: At the check out patient was standing and then fell on the floor was taken to the room. She was awake, alert, vital signs were normal, stayed in the room for 15-20 minutes and left when she felt better.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site discolouration, Injection site induration, Injection site warmth
Clinical narrative: About 7 cm symmetric pink minimally warm non tender minimally indurated pruritic pink circle at post injection region L thigh
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Herpes zoster
Clinical narrative: Pt was seen by chiropractor 3 mo after pt received Flu vaccine and was diagnosed as to having shingles. Chiropractor said she had seen several similar situations recently.
Age: 43.0
Sex: F
Vaccine: MNQ
Symptoms: Arthralgia, Culture stool negative, Diarrhoea, Full blood count normal, Myalgia
Clinical narrative: Intital report received from a health care professional in the USA on 15, March 2007, A 43 year old, female patient (with an allergy to sulfa) developed joint and muscle pain, diarrhea and an erythematous papular full body rash, within 12 hours after she received Menactra ( lot # U2002AC) intramuscularly in the deltoid on 02, February 2007 - due to possible exposure. At the time of the vaccination, she had a urinary tract infection and was taking Orthonovum. She was seen and evaluated by a doctor on 04, March 2007. Stool cultures and CBCs were completed. the results were not available. At the time of the report, the symptoms still persist and the patient was not recovered. Follow-up information received on 22-June 2007 from a heThis case halth care professional. The patient had not been back to the office for follow-up as she was called in follow-up on 05-June 2007. She stated that she still had rash off and on, nausea, and tooth pain with negative exam by the dentist. She also had headaches. Stool cultures were negative and CBC and metabolic panel were essentially normal. The patient stated that she had not felt normal since the immunization. This case has the same reporter as case 2007-00799
Age: 43.0
Sex: F
Vaccine: MNQ
Symptoms: Rash erythematous, Rash generalised, Rash papular
Clinical narrative: Intital report received from a health care professional in the USA on 15, March 2007, A 43 year old, female patient (with an allergy to sulfa) developed joint and muscle pain, diarrhea and an erythematous papular full body rash, within 12 hours after she received Menactra ( lot # U2002AC) intramuscularly in the deltoid on 02, February 2007 - due to possible exposure. At the time of the vaccination, she had a urinary tract infection and was taking Orthonovum. She was seen and evaluated by a doctor on 04, March 2007. Stool cultures and CBCs were completed. the results were not available. At the time of the report, the symptoms still persist and the patient was not recovered. Follow-up information received on 22-June 2007 from a heThis case halth care professional. The patient had not been back to the office for follow-up as she was called in follow-up on 05-June 2007. She stated that she still had rash off and on, nausea, and tooth pain with negative exam by the dentist. She also had headaches. Stool cultures were negative and CBC and metabolic panel were essentially normal. The patient stated that she had not felt normal since the immunization. This case has the same reporter as case 2007-00799
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Arthralgia, Condition aggravated, Cough, Culture stool, Diarrhoea
Clinical narrative: Initial report received from a health care professional in the USA on 15, March 2007. A 17 year old female patient developed joint and muscle pain, diarrhea and an erythematous papular full body rash, within 12 hours after she received Menactra (lot # U2002AC) intramuscularly in the deltoid on 05, February 2007. She was seen and evaluated by a doctor on 14, March 2007. Stool cultures and CBC were completed, the results were not available. At the time of the report, the symptoms still persist and the patient was not recovered. This case has the same reporter as case 2007-00798. Follow up information received on 22 June 2007 from a health care professional. Illness at the time of vaccinaiton included myalgia, pharyngitis, cough and headaches. The patient had also been exposed to viral meningitis. She did not follow up for the CBC and stool cultures. In return visits on 09 February 2007, 17 March 2007, and 21 May 2007 (all for pharyngitis), the patient did not complain of symptom due to the immunization. However, in a conversation with the patient's mother on 05 June 2007, the patient stated that "she still has joint pain in her knees and rash off and on." This case has th esame reporter as 2007-00708.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Full blood count, Headache, Myalgia, Myalgia, Pharyngitis
Clinical narrative: Initial report received from a health care professional in the USA on 15, March 2007. A 17 year old female patient developed joint and muscle pain, diarrhea and an erythematous papular full body rash, within 12 hours after she received Menactra (lot # U2002AC) intramuscularly in the deltoid on 05, February 2007. She was seen and evaluated by a doctor on 14, March 2007. Stool cultures and CBC were completed, the results were not available. At the time of the report, the symptoms still persist and the patient was not recovered. This case has the same reporter as case 2007-00798. Follow up information received on 22 June 2007 from a health care professional. Illness at the time of vaccinaiton included myalgia, pharyngitis, cough and headaches. The patient had also been exposed to viral meningitis. She did not follow up for the CBC and stool cultures. In return visits on 09 February 2007, 17 March 2007, and 21 May 2007 (all for pharyngitis), the patient did not complain of symptom due to the immunization. However, in a conversation with the patient's mother on 05 June 2007, the patient stated that "she still has joint pain in her knees and rash off and on." This case has th esame reporter as 2007-00708.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Rash generalised, Rash papular
Clinical narrative: Initial report received from a health care professional in the USA on 15, March 2007. A 17 year old female patient developed joint and muscle pain, diarrhea and an erythematous papular full body rash, within 12 hours after she received Menactra (lot # U2002AC) intramuscularly in the deltoid on 05, February 2007. She was seen and evaluated by a doctor on 14, March 2007. Stool cultures and CBC were completed, the results were not available. At the time of the report, the symptoms still persist and the patient was not recovered. This case has the same reporter as case 2007-00798. Follow up information received on 22 June 2007 from a health care professional. Illness at the time of vaccinaiton included myalgia, pharyngitis, cough and headaches. The patient had also been exposed to viral meningitis. She did not follow up for the CBC and stool cultures. In return visits on 09 February 2007, 17 March 2007, and 21 May 2007 (all for pharyngitis), the patient did not complain of symptom due to the immunization. However, in a conversation with the patient's mother on 05 June 2007, the patient stated that "she still has joint pain in her knees and rash off and on." This case has th esame reporter as 2007-00708.
Age: 53.0
Sex: F
Vaccine: TTOX
Symptoms: Erythema, Nodule, Pain, Swelling
Clinical narrative: Lump, redness, swelling, very sore
Age: 84.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site erythema, Injection site nodule, Injection site pain
Clinical narrative: Lump at site, soreness, redness
Age: 66.0
Sex: F
Vaccine: TTOX
Symptoms: Erythema, Pain
Clinical narrative: Very sore, redness
Age: 78.0
Sex: F
Vaccine: TTOX
Symptoms: Erythema, Pain
Clinical narrative: Redness, very sore
Age: 61.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Redness and tenderness at site. Redness was the size of a dime.
Age: 39.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Pallor
Clinical narrative: Redness no pain at site. On exam 6x6 cm tender blanchable, erythema was noted over left deltoid. DX: cellulitis. Treatment: Keflex x 10 days.
Age: 28.0
Sex: F
Vaccine: TTOX
Symptoms: Erythema, Nodule, Pain
Clinical narrative: Lump, redness, very sore
Sex: F
Vaccine: UNK
Symptoms: Culture, Injection site vesicles
Clinical narrative: Patient given multiple vaccines 4/3/07. Patient brought in 4/4/07 with blisters at one injection site left deltoid region
Sex: F
Vaccine: UNK
Symptoms: Culture, Injection site vesicles
Clinical narrative: Patient given multiple immunization 4/3/07. Patient brought in on 4/4/07 with blister at one injection site left deltoid region
Age: 0.35
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Haematochezia, Irritability, Mucous stools, Stomach discomfort
Clinical narrative: Rotateq given on 2/6/07, patient was 4 mos old 48 hrs later, mom noted immobility and huge amounts bright red blood mixed in with stool in sheet and also mucousy, no fever. 2 weeks later, had long smelly large amounts of mucous and mixed with bright red blood. Pt was fussy and stomach was "rumbling", no fever, no vomiting. Rotateq given 12/5/06 24-48 hrs later had stool with very small amount of blood, fussiness, didn't inform MD
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Contraindication to vaccination, Glucose tolerance impaired
Clinical narrative: Varivax in pt with diagnosis of CLL
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash erythematous
Clinical narrative: erythematous raised lesion 4cm x 5cm, irregular negative pruritus
Age: 16.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Pain in extremity, Rash papular, Skin warm
Clinical narrative: Pt had 3 x 4 cm red, raised area right deltoid from pneumonia vac. c/o pain in arm across shoulders arm red warm to touch localized elevated temp. Treated with topical steroids. Benadryl and tylenol returned to clinic on Thur to see doctor and area was smaller.
Age: 15.0
Sex: F
Vaccine: JEV, RAB
Symptoms: Body temperature increased, Headache, Injection site pain, Malaise
Clinical narrative: one week after # 2 JE and Rabies client's aunt reported that client had a temp 100.5 po on Tylenol tue pm after #2 doses. site was tender but no red or inflamed. General malaise and headache also reported. Did not go to school for one day. Resolved.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Headache, Injection site erythema, Injection site swelling
Clinical narrative: after immunization left thigh became red and swollen c/o headache not feeling well
Age: 20.0
Sex: M
Vaccine: HEP
Symptoms: Abdominal pain, Chills, Cold sweat, Dizziness, Feeling abnormal
Clinical narrative: Received injection 4-5-07 at 7:45 am states he didn't feel well that night 4-6-07 woke up with a headache, chills, cold sweat, face flushes. Vomited once, dizziness and abd pain LVQ.  Treatment-Phenergan 25 mg I PO q 4-6 hours prn. BP 124/69, P 80, 98 deg
Age: 20.0
Sex: M
Vaccine: HEP
Symptoms: Flushing, Headache, Vomiting
Clinical narrative: Received injection 4-5-07 at 7:45 am states he didn't feel well that night 4-6-07 woke up with a headache, chills, cold sweat, face flushes. Vomited once, dizziness and abd pain LVQ.  Treatment-Phenergan 25 mg I PO q 4-6 hours prn. BP 124/69, P 80, 98 deg
Age: 37.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Albumin urine, Amino acid level, Asthenia, Blood alkaline phosphatase normal, Blood calcium normal
Clinical narrative: 39-year-old ADA WM who was in his usual state of excellent health until he was diagnosed with Type I diabetes mellitus in September 2006. Service member received his Hepatitis B (2) vaccination in Jan 2005. He denies any unusual vaccine site reactions or unusual or prolonged systemic symptoms within first week of vaccine receipt. He received his first 4 AVA immunizations between Mar and Oct 2004. He noted some soreness and a small nodule lasting about 2 days following each vaccine, but denies any unusual or persistent vaccine site reactions or systemic symptoms. In April 2004, service member received his SPV (2) in his upper left arm (15 jabs). He recalls that his smallpox vaccine site progressed as expected and was assessed as a 'take'. He denies axillary lymphadenopathy. He does not recall any unusual or persistent vaccine site reactions or systemic symptoms. Looking back, the first symptoms that the service member can recall are blurry vision and fatigue. The blurry vision was noted around August 2006. Service member attributed visual changes to exposure to cigarette smoke affecting eyes (had just re-started smoking) and did not seek medical evaluation. He began noting an increase in fatigue around July 2006. In late June, his unit was ordered to stop PT in order to concentrate more on Deployment. They were required to work long hours. When he noted feeling more fatigued, he attributed it to working long hours and the lack of exercise. Around August, he was waking up 'fully changed', but by 1400 or 1500, he was 'pooped' and ready for a nap. He rates his energy level as 60-75% using a scale of 0 (=baseline energy level) to 100 (=no energy/bedridden). He later developed polydipsia and polyuria which began around the middle of August 2006. He did not experience weight loss or paresthesias. (Between June and Sept, he had actually gained about 15-20 pounds after regular exercise was discontinued.) In mid-September 2006, service member had lab work done as part of predeployment process and SRP. His glucose levels in his urine and blood were elevated. He was diagnosed with diabetes a few days later (after the weekend). He was initially started on oral medications and taught self blood glucose monitoring as an outpatient.  His blood glucose levels were running in the low to high 300-400s. His pills were increased and his BGs levels decreased to the 200-300 range. About 1 week after diagnosis, he was evaluated by an endocrinologist who had him complete additional labwork. Because he was GAD antibody positive, which is consistent with Type 1 diabetes, his oral medication were discontinued and insulin was initiated. Service member has a family history of Type 1 diabetes (brother-diagnosed around age 10). He denies symptoms of viral or bacterial infections prior to symptom onset.
Age: 37.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Blood chloride normal, Blood cholesterol increased, Blood glucose, Blood ketone body, Blood potassium decreased
Clinical narrative: 39-year-old ADA WM who was in his usual state of excellent health until he was diagnosed with Type I diabetes mellitus in September 2006. Service member received his Hepatitis B (2) vaccination in Jan 2005. He denies any unusual vaccine site reactions or unusual or prolonged systemic symptoms within first week of vaccine receipt. He received his first 4 AVA immunizations between Mar and Oct 2004. He noted some soreness and a small nodule lasting about 2 days following each vaccine, but denies any unusual or persistent vaccine site reactions or systemic symptoms. In April 2004, service member received his SPV (2) in his upper left arm (15 jabs). He recalls that his smallpox vaccine site progressed as expected and was assessed as a 'take'. He denies axillary lymphadenopathy. He does not recall any unusual or persistent vaccine site reactions or systemic symptoms. Looking back, the first symptoms that the service member can recall are blurry vision and fatigue. The blurry vision was noted around August 2006. Service member attributed visual changes to exposure to cigarette smoke affecting eyes (had just re-started smoking) and did not seek medical evaluation. He began noting an increase in fatigue around July 2006. In late June, his unit was ordered to stop PT in order to concentrate more on Deployment. They were required to work long hours. When he noted feeling more fatigued, he attributed it to working long hours and the lack of exercise. Around August, he was waking up 'fully changed', but by 1400 or 1500, he was 'pooped' and ready for a nap. He rates his energy level as 60-75% using a scale of 0 (=baseline energy level) to 100 (=no energy/bedridden). He later developed polydipsia and polyuria which began around the middle of August 2006. He did not experience weight loss or paresthesias. (Between June and Sept, he had actually gained about 15-20 pounds after regular exercise was discontinued.) In mid-September 2006, service member had lab work done as part of predeployment process and SRP. His glucose levels in his urine and blood were elevated. He was diagnosed with diabetes a few days later (after the weekend). He was initially started on oral medications and taught self blood glucose monitoring as an outpatient.  His blood glucose levels were running in the low to high 300-400s. His pills were increased and his BGs levels decreased to the 200-300 range. About 1 week after diagnosis, he was evaluated by an endocrinologist who had him complete additional labwork. Because he was GAD antibody positive, which is consistent with Type 1 diabetes, his oral medication were discontinued and insulin was initiated. Service member has a family history of Type 1 diabetes (brother-diagnosed around age 10). He denies symptoms of viral or bacterial infections prior to symptom onset.
Age: 37.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Blood sodium normal, Blood urea decreased, Diabetes mellitus, Familial risk factor, Fatigue
Clinical narrative: 39-year-old ADA WM who was in his usual state of excellent health until he was diagnosed with Type I diabetes mellitus in September 2006. Service member received his Hepatitis B (2) vaccination in Jan 2005. He denies any unusual vaccine site reactions or unusual or prolonged systemic symptoms within first week of vaccine receipt. He received his first 4 AVA immunizations between Mar and Oct 2004. He noted some soreness and a small nodule lasting about 2 days following each vaccine, but denies any unusual or persistent vaccine site reactions or systemic symptoms. In April 2004, service member received his SPV (2) in his upper left arm (15 jabs). He recalls that his smallpox vaccine site progressed as expected and was assessed as a 'take'. He denies axillary lymphadenopathy. He does not recall any unusual or persistent vaccine site reactions or systemic symptoms. Looking back, the first symptoms that the service member can recall are blurry vision and fatigue. The blurry vision was noted around August 2006. Service member attributed visual changes to exposure to cigarette smoke affecting eyes (had just re-started smoking) and did not seek medical evaluation. He began noting an increase in fatigue around July 2006. In late June, his unit was ordered to stop PT in order to concentrate more on Deployment. They were required to work long hours. When he noted feeling more fatigued, he attributed it to working long hours and the lack of exercise. Around August, he was waking up 'fully changed', but by 1400 or 1500, he was 'pooped' and ready for a nap. He rates his energy level as 60-75% using a scale of 0 (=baseline energy level) to 100 (=no energy/bedridden). He later developed polydipsia and polyuria which began around the middle of August 2006. He did not experience weight loss or paresthesias. (Between June and Sept, he had actually gained about 15-20 pounds after regular exercise was discontinued.) In mid-September 2006, service member had lab work done as part of predeployment process and SRP. His glucose levels in his urine and blood were elevated. He was diagnosed with diabetes a few days later (after the weekend). He was initially started on oral medications and taught self blood glucose monitoring as an outpatient.  His blood glucose levels were running in the low to high 300-400s. His pills were increased and his BGs levels decreased to the 200-300 range. About 1 week after diagnosis, he was evaluated by an endocrinologist who had him complete additional labwork. Because he was GAD antibody positive, which is consistent with Type 1 diabetes, his oral medication were discontinued and insulin was initiated. Service member has a family history of Type 1 diabetes (brother-diagnosed around age 10). He denies symptoms of viral or bacterial infections prior to symptom onset.
Age: 37.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Full blood count, Glycosylated haemoglobin increased, Haematocrit decreased, Haemoglobin increased, High density lipoprotein increased
Clinical narrative: 39-year-old ADA WM who was in his usual state of excellent health until he was diagnosed with Type I diabetes mellitus in September 2006. Service member received his Hepatitis B (2) vaccination in Jan 2005. He denies any unusual vaccine site reactions or unusual or prolonged systemic symptoms within first week of vaccine receipt. He received his first 4 AVA immunizations between Mar and Oct 2004. He noted some soreness and a small nodule lasting about 2 days following each vaccine, but denies any unusual or persistent vaccine site reactions or systemic symptoms. In April 2004, service member received his SPV (2) in his upper left arm (15 jabs). He recalls that his smallpox vaccine site progressed as expected and was assessed as a 'take'. He denies axillary lymphadenopathy. He does not recall any unusual or persistent vaccine site reactions or systemic symptoms. Looking back, the first symptoms that the service member can recall are blurry vision and fatigue. The blurry vision was noted around August 2006. Service member attributed visual changes to exposure to cigarette smoke affecting eyes (had just re-started smoking) and did not seek medical evaluation. He began noting an increase in fatigue around July 2006. In late June, his unit was ordered to stop PT in order to concentrate more on Deployment. They were required to work long hours. When he noted feeling more fatigued, he attributed it to working long hours and the lack of exercise. Around August, he was waking up 'fully changed', but by 1400 or 1500, he was 'pooped' and ready for a nap. He rates his energy level as 60-75% using a scale of 0 (=baseline energy level) to 100 (=no energy/bedridden). He later developed polydipsia and polyuria which began around the middle of August 2006. He did not experience weight loss or paresthesias. (Between June and Sept, he had actually gained about 15-20 pounds after regular exercise was discontinued.) In mid-September 2006, service member had lab work done as part of predeployment process and SRP. His glucose levels in his urine and blood were elevated. He was diagnosed with diabetes a few days later (after the weekend). He was initially started on oral medications and taught self blood glucose monitoring as an outpatient.  His blood glucose levels were running in the low to high 300-400s. His pills were increased and his BGs levels decreased to the 200-300 range. About 1 week after diagnosis, he was evaluated by an endocrinologist who had him complete additional labwork. Because he was GAD antibody positive, which is consistent with Type 1 diabetes, his oral medication were discontinued and insulin was initiated. Service member has a family history of Type 1 diabetes (brother-diagnosed around age 10). He denies symptoms of viral or bacterial infections prior to symptom onset.
Age: 37.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Low density lipoprotein increased, Nodule, Pain, Platelet count decreased, Polydipsia
Clinical narrative: 39-year-old ADA WM who was in his usual state of excellent health until he was diagnosed with Type I diabetes mellitus in September 2006. Service member received his Hepatitis B (2) vaccination in Jan 2005. He denies any unusual vaccine site reactions or unusual or prolonged systemic symptoms within first week of vaccine receipt. He received his first 4 AVA immunizations between Mar and Oct 2004. He noted some soreness and a small nodule lasting about 2 days following each vaccine, but denies any unusual or persistent vaccine site reactions or systemic symptoms. In April 2004, service member received his SPV (2) in his upper left arm (15 jabs). He recalls that his smallpox vaccine site progressed as expected and was assessed as a 'take'. He denies axillary lymphadenopathy. He does not recall any unusual or persistent vaccine site reactions or systemic symptoms. Looking back, the first symptoms that the service member can recall are blurry vision and fatigue. The blurry vision was noted around August 2006. Service member attributed visual changes to exposure to cigarette smoke affecting eyes (had just re-started smoking) and did not seek medical evaluation. He began noting an increase in fatigue around July 2006. In late June, his unit was ordered to stop PT in order to concentrate more on Deployment. They were required to work long hours. When he noted feeling more fatigued, he attributed it to working long hours and the lack of exercise. Around August, he was waking up 'fully changed', but by 1400 or 1500, he was 'pooped' and ready for a nap. He rates his energy level as 60-75% using a scale of 0 (=baseline energy level) to 100 (=no energy/bedridden). He later developed polydipsia and polyuria which began around the middle of August 2006. He did not experience weight loss or paresthesias. (Between June and Sept, he had actually gained about 15-20 pounds after regular exercise was discontinued.) In mid-September 2006, service member had lab work done as part of predeployment process and SRP. His glucose levels in his urine and blood were elevated. He was diagnosed with diabetes a few days later (after the weekend). He was initially started on oral medications and taught self blood glucose monitoring as an outpatient.  His blood glucose levels were running in the low to high 300-400s. His pills were increased and his BGs levels decreased to the 200-300 range. About 1 week after diagnosis, he was evaluated by an endocrinologist who had him complete additional labwork. Because he was GAD antibody positive, which is consistent with Type 1 diabetes, his oral medication were discontinued and insulin was initiated. Service member has a family history of Type 1 diabetes (brother-diagnosed around age 10). He denies symptoms of viral or bacterial infections prior to symptom onset.
Age: 37.0
Sex: M
Vaccine: ANTH, HEP, TYP
Symptoms: Polyuria, Red blood cell count decreased, Vision blurred, Weight increased, White blood cell count
Clinical narrative: 39-year-old ADA WM who was in his usual state of excellent health until he was diagnosed with Type I diabetes mellitus in September 2006. Service member received his Hepatitis B (2) vaccination in Jan 2005. He denies any unusual vaccine site reactions or unusual or prolonged systemic symptoms within first week of vaccine receipt. He received his first 4 AVA immunizations between Mar and Oct 2004. He noted some soreness and a small nodule lasting about 2 days following each vaccine, but denies any unusual or persistent vaccine site reactions or systemic symptoms. In April 2004, service member received his SPV (2) in his upper left arm (15 jabs). He recalls that his smallpox vaccine site progressed as expected and was assessed as a 'take'. He denies axillary lymphadenopathy. He does not recall any unusual or persistent vaccine site reactions or systemic symptoms. Looking back, the first symptoms that the service member can recall are blurry vision and fatigue. The blurry vision was noted around August 2006. Service member attributed visual changes to exposure to cigarette smoke affecting eyes (had just re-started smoking) and did not seek medical evaluation. He began noting an increase in fatigue around July 2006. In late June, his unit was ordered to stop PT in order to concentrate more on Deployment. They were required to work long hours. When he noted feeling more fatigued, he attributed it to working long hours and the lack of exercise. Around August, he was waking up 'fully changed', but by 1400 or 1500, he was 'pooped' and ready for a nap. He rates his energy level as 60-75% using a scale of 0 (=baseline energy level) to 100 (=no energy/bedridden). He later developed polydipsia and polyuria which began around the middle of August 2006. He did not experience weight loss or paresthesias. (Between June and Sept, he had actually gained about 15-20 pounds after regular exercise was discontinued.) In mid-September 2006, service member had lab work done as part of predeployment process and SRP. His glucose levels in his urine and blood were elevated. He was diagnosed with diabetes a few days later (after the weekend). He was initially started on oral medications and taught self blood glucose monitoring as an outpatient.  His blood glucose levels were running in the low to high 300-400s. His pills were increased and his BGs levels decreased to the 200-300 range. About 1 week after diagnosis, he was evaluated by an endocrinologist who had him complete additional labwork. Because he was GAD antibody positive, which is consistent with Type 1 diabetes, his oral medication were discontinued and insulin was initiated. Service member has a family history of Type 1 diabetes (brother-diagnosed around age 10). He denies symptoms of viral or bacterial infections prior to symptom onset.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Developed approximately 5cm by 6cm erythema, swollen area at site of injection approximately 24 hours after administration. Hot and hard to touch.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site urticaria
Clinical narrative: Wheals appeared on left thigh where varicella was given.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, VARCEL
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: 3" Area redness and itching at injection site left upper arm/deltoid.
Age: 0.15
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Body temperature increased, Irritability, Muscle twitching, Sleep disorder
Clinical narrative: 4-6 Hours after immunizations were given, she became irritable, had an abnormal sleep pattern and twitching of one side of her face, according to her mother, lasting about 10 minutes. Her temperature was 100.5 and mother gave Tylenol. She was less irritable the next morning. She was seen by a neurologist, exam was normal and suggested pertussis should be omitted in the future.